tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ryan Macdonald, 401 are a BUY (89.31%), 45 are a HOLD (10.02%), 3 are a SELL (0.67%).
Analyst Ryan Macdonald, currently employed at NEEDHAM, carries an average stock price target met ratio of 55.73% that have a potential upside of 52.37% achieved within 146 days.
Ryan Macdonald’s has documented 839 price targets and ratings displayed on 46 stocks. The coverage is on Technology, Healthcare, Consumer Defensive, Industrials sectors.
Most recent stock forecast was given on HIMS, Hims Hers Health at 23-Jun-2025.
Analyst best performing recommendations are on HIMS (HIMS HERS HEALTH).
The best stock recommendation documented was for HIMS (HIMS HERS HEALTH) at 4/25/2025. The price target of $61 was fulfilled within 54 days with a profit of $56.4 (1226.09%) receiving and performance score of 227.05.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$675
$150.73 (28.75%)
$700
1 months 4 days ago
(09-Jun-2025)
20/26 (76.92%)
$68.94 (11.38%)
171
Buy
$752
$227.73 (43.44%)
$659
2 months 4 days ago
(09-May-2025)
11/14 (78.57%)
$148.95 (24.70%)
152
Hold
$645
$120.73 (23.03%)
$535
2 months 4 days ago
(09-May-2025)
32/32 (100%)
$41.95 (6.96%)
140
Buy
$825
$300.73 (57.36%)
$980
2 months 4 days ago
(09-May-2025)
17/20 (85%)
$221.95 (36.80%)
178
Buy
$795
$270.73 (51.64%)
$900
2 months 4 days ago
(09-May-2025)
3/6 (50%)
$191.95 (31.83%)
83
Which stock is Ryan Macdonald is most bullish on?
Which stock is Ryan Macdonald is most reserved on?
What Year was the first public recommendation made by Ryan Macdonald?
